SCHEMBL30906358

CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C

nearest known ligand 0.59

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	7/20	0.56

▸	NPY4R	P50391	7/20	0.56

▸	NPY5R	Q15761	7/20	0.56

▸	NPY1R	P25929	5/20	0.56

▸	RAMP3	O60896	10/20	0.55

▸	CALCR	P30988	10/20	0.55

▸	EP300	Q09472	1/20	0.53

▸	HIF1A	Q16665	1/20	0.53

▸	KDM1A	O60341	1/20	0.52

▸	MAOB	P27338	1/20	0.52

▸	KDM5A	P29375	1/20	0.52

▸	KDM1B	Q8NB78	1/20	0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906501	1.00	NPY2R (0.56)	NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30906413	0.99	NPY2R (0.57)	NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30906458	0.99	NPY2R (0.57)	NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30906340	0.98	NPY2R (0.57)	NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30906335	0.98	RAMP3 (0.56)	NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30906443	0.98	RAMP3 (0.56)	NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30906414	0.97	NPY2R (0.56)	NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30906534	0.96	RAMP3 (0.55)	NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30906369	0.96	RAMP3 (0.57)	NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30906350	0.95	NPY2R (0.59)	NPY2RNPY4RNPY5RNPY1RRAMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed